SCHEMBL7814769

SCHEMBL7814769

Nc1ccc(-c2nc3c(s2)C(=O)c2ccccc2C3=O)o1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 7/20 0.55
▸ TDO2 P48775 5/20 0.55
▸ ADORA1 P30542 6/20 0.39
▸ ADORA2A P29274 5/20 0.39
▸ USP8 P40818 1/20 0.37
▸ USP1 O94782 2/20 0.35
▸ USP19 O94966 2/20 0.35
▸ WDR48 Q8TAF3 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ UCHL3 P15374 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813124 0.83 IDO1 (0.55) IDO1TDO2USP1USP19WDR48
SCHEMBL7811891 0.83 IDO1 (0.55) IDO1TDO2ADORA1ADORA2AUSP1
SCHEMBL7808342 0.83 IDO1 (0.55) IDO1TDO2ADORA1ADORA2AUSP1
SCHEMBL7812948 0.81 IDO1 (0.52) IDO1TDO2ALDH1A1MAPTRAB9A
SCHEMBL7811413 0.79 IDO1 (0.50) IDO1TDO2RAB9ANPC1
SCHEMBL7816639 0.77 IDO1 (0.57) IDO1TDO2ADORA1ADORA2AALDH1A1
SCHEMBL7805846 0.77 IDO1 (0.48) IDO1TDO2ALDH1A1MAPTRAB9A
SCHEMBL7807731 0.76 IDO1 (0.52) IDO1TDO2USP8USP1USP19
SCHEMBL7811377 0.76 IDO1 (0.52) IDO1TDO2USP1USP19WDR48
SCHEMBL7811740 0.74 IDO1 (0.45) IDO1TDO2ALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP claimed
EP-0876356-A1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF LABORATOIRE INNOTHERA Société Anonyme (FR) 1998-11-11 — — EP claimed
WO-1997021684-A1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF LABORATOIRE INNOTHERA, SOCIETE ANONYME (FR) 1997-06-19 — — WO claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 — — US disclosed
Send feedback